While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, leaving cell and gene therapy behind.

I’m in London, and I just paid for this damn fat drug I take. I said, it’s not working. They said, he said, I just paid $88 ...

Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple ...

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) antagonist, SC0062, a second BTD.

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...

The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use ...